Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
333.50 GBX | +4.66% |
|
+2.43% | +24.37% |
Jun. 24 | Piraeus Financial Holdings Successfully Priced a ?400 Million Additional Tier 1 Instrument | CI |
Jun. 24 | FTSE 100 underperforms despite Iran-Israel hope | AN |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Interest Income On Loans | 11.89B | 11.24B | 19.1B | 35.08B | 38.33B | |||||
Interest Income, Total | 11.89B | 11.24B | 19.1B | 35.08B | 38.33B | |||||
Interest On Deposits | 3.77B | 3.17B | 8.52B | 22.37B | 25.39B | |||||
Interest Expense, Total | 3.77B | 3.17B | 8.52B | 22.37B | 25.39B | |||||
Net Interest Income | 8.12B | 8.07B | 10.57B | 12.71B | 12.94B | |||||
Income From Trading Activities | 7.03B | 5.79B | 8.05B | 5.94B | 5.77B | |||||
Gain (Loss) on Sale of Assets | 17M | - | - | - | - | |||||
Gain (Loss) on Sale of Invest. & Securities - (Rev) | -208M | -201M | -285M | -119M | -68M | |||||
Total Other Non Interest Income | 6.94B | 8.27B | 6.62B | 6.84B | 7.6B | |||||
Non Interest Income, Total | 13.78B | 13.87B | 14.38B | 12.67B | 13.3B | |||||
Revenues Before Provison For Loan Losses | 21.9B | 21.94B | 24.96B | 25.38B | 26.23B | |||||
Provision For Loan Losses | 4.84B | -653M | 1.22B | 1.88B | 1.98B | |||||
Total Revenues | 17.06B | 22.59B | 23.74B | 23.5B | 24.25B | |||||
Salaries And Other Employee Benefits | 7.56B | 7.74B | 8.75B | 9.09B | 9.13B | |||||
Selling General & Admin Expenses, Total | 5.87B | 5.82B | 6.33B | 6.99B | 6.79B | |||||
(Income) Loss on Equity Invest. | -6M | -260M | -6M | 9M | -37M | |||||
Total Other Non Interest Expense | - | - | - | - | 320M | |||||
Non Interest Expense, Total | 13.43B | 13.3B | 15.07B | 16.09B | 16.21B | |||||
EBT, Excl. Unusual Items | 3.63B | 9.29B | 8.66B | 7.41B | 8.04B | |||||
Restructuring Charges | -102M | -562M | 7M | -452M | -235M | |||||
Impairment of Goodwill | - | - | - | -33M | - | |||||
Asset Writedown | -194M | -137M | -63M | -330M | -34M | |||||
Legal Settlements | -153M | -177M | -1.6B | -37M | -220M | |||||
Other Unusual Items | -115M | - | - | - | 556M | |||||
EBT, Incl. Unusual Items | 3.06B | 8.41B | 7.01B | 6.56B | 8.11B | |||||
Income Tax Expense | 604M | 1.19B | 1.04B | 1.23B | 1.75B | |||||
Earnings From Continuing Operations | 2.46B | 7.23B | 5.97B | 5.32B | 6.36B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 2.46B | 7.23B | 5.97B | 5.32B | 6.36B | |||||
Minority Interest | -78M | -47M | -45M | -64M | -49M | |||||
Net Income - (IS) | 2.38B | 7.18B | 5.93B | 5.26B | 6.31B | |||||
Preferred Dividend and Other Adjustments | 857M | 804M | 905M | 985M | 991M | |||||
Net Income to Common Incl Extra Items | 1.53B | 6.38B | 5.02B | 4.27B | 5.32B | |||||
Net Income to Common Excl. Extra Items | 1.53B | 6.38B | 5.02B | 4.27B | 5.32B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.09 | 0.38 | 0.31 | 0.28 | 0.36 | |||||
Basic EPS - Continuing Operations | 0.09 | 0.38 | 0.31 | 0.28 | 0.36 | |||||
Basic Weighted Average Shares Outstanding | 17.3B | 16.98B | 16.33B | 15.44B | 14.76B | |||||
Net EPS - Diluted | 0.09 | 0.37 | 0.3 | 0.27 | 0.35 | |||||
Diluted EPS - Continuing Operations | 0.09 | 0.37 | 0.3 | 0.27 | 0.35 | |||||
Diluted Weighted Average Shares Outstanding | 17.67B | 17.42B | 16.87B | 15.9B | 15.27B | |||||
Normalized Basic EPS | 0.13 | 0.34 | 0.33 | 0.3 | 0.34 | |||||
Normalized Diluted EPS | 0.12 | 0.33 | 0.32 | 0.29 | 0.33 | |||||
Dividend Per Share | 0.01 | 0.06 | 0.07 | 0.08 | 0.08 | |||||
Payout Ratio | 35.96 | 18.33 | 32.61 | 41.74 | 35.07 | |||||
American Depositary Receipts Ratio (ADR) | 4 | 4 | 4 | 4 | 4 | |||||
Supplemental Items | ||||||||||
Effective Tax Rate - (Ratio) | 19.71 | 14.12 | 14.82 | 18.82 | 21.61 | |||||
Total Current Taxes | 1.29B | 1.78B | 601M | 1.18B | 1.66B | |||||
Total Deferred Taxes | -682M | -596M | 438M | 56M | 93M | |||||
Normalized Net Income | 2.19B | 5.76B | 5.37B | 4.57B | 4.98B | |||||
Non-Cash Pension Expense | -43M | -23M | -99M | -219M | -153M | |||||
Supplemental Operating Expense Items | ||||||||||
Stock-Based Comp., SG&A Exp. (Total) | 431M | 477M | 513M | 479M | 507M | |||||
Total Stock-Based Compensation | 431M | 477M | 513M | 479M | 507M |
- Stock Market
- Equities
- BARC Stock
- Financials Barclays PLC
- Income Statement
Select your edition
All financial news and data tailored to specific country editions